Earn-Out Measurement Board Examiner — Life Sciences Acquisition

The mandate

The board repeatedly asks whether revenue, instrument-placement and development milestones are being measured consistently with the acquisition agreement while the parent changes pricing, channel, investment and product priorities. Earn-out forecasts affect reported contingent consideration, but operational choices also influence what sellers may ultimately receive. Directors need a disciplined challenge before accounting estimates and contractual disputes reinforce one another.

The examiner will reserve two days monthly for committee preparation, measurement-pack review and private sessions with group and acquired-company leaders, plus five Basel meetings. A written challenge to a material milestone or fair-value change is due within two Swiss business days. Calculation work, valuation, legal interpretation, negotiation or dispute support requires a separate mandate.

The appointment lasts ten months from February 2027. At month eight, management must defend an unseen channel transfer, delayed development spend and measurement correction. Renewal is limited to one board-approved extension of up to three months for a named reporting or dispute milestone; unused access expires and may not become routine transaction-accounting work.

The examiner has no line authority, executive authority, statutory-director duty, accounting-signing right, audit role, valuation opinion, legal mandate, arbitration role or settlement power. Management prepares estimates; auditors and specialists issue their conclusions; authorised parties interpret the contract. Advice cannot be represented as an earn-out determination, fairness view or dispute outcome.

Interests involving the seller, acquired executives, major customers, valuation firms, auditors, transaction advisers, litigation funders or competing acquirers must be disclosed as conflicts. One unrelated transaction-governance role may continue with chair consent. Contingent compensation linked to milestone achievement, fair value, seller recovery or settlement is incompatible with the appointment.

Why the board wants this voice

Group Finance understands acquisition accounting and counsel understands the agreement, yet the board lacks an operator who has governed earn-out evidence while integration changes the business being measured. The missing voice can expose incentive and control problems without becoming contract interpreter, valuer, auditor or advocate for either buyer or seller.

What you will own

• Press directors to reconcile contractual metric, operating source, accounting estimate, forecast assumption and responsible management action.
• Test revenue and placement measures for channel transfer, bundling, returns, currency, related parties, product substitution and cut-off.
• Challenge development milestones where parent resource allocation, evidence timing or changed technical criteria affect achievement.
• Frame scenarios for discontinued product, delayed investment, customer migration, corrected source data and disputed management discretion.
• Probe contingent-consideration assumptions for probability, timing, discounting, volatility, bias and consistency with operating plans.
• Examine governance of seller access, management certification, independent review, dispute notices and preserved original evidence.
• Coach directors to separate contract measurement, accounting fair value, integration decision and negotiation posture.

Candidate qualifications

• Held senior transaction-accounting, acquisition-governance or finance oversight authority involving material earn-outs or contingent value rights.
• Governed operational metric evidence and fair-value assumptions where integration choices could affect seller consideration.
• Challenged revenue, product and development milestones through channel changes, investment delays and disputed management discretion.
• Presented contingent-consideration movements to boards, auditors and transaction counsel without issuing valuation or legal conclusions.
• Designed preserved evidence and seller-access controls that reduced later measurement disputes under a live acquisition agreement.
• Managed conflicts among buyer, seller, executives, advisers, auditors and valuers while handling commercially sensitive forecasts.

Non-negotiables

• Can attend all five Basel sessions and respond within two business days to a declared milestone-measurement issue.
• Will disclose seller, executive, customer, auditor, valuer, adviser and litigation interests before evidence access.
• Accepts literal absence of line, executive, director, accounting-signing, audit, valuation, legal, arbitration and settlement authority.
• Must evidence a consequential earn-out or contingent-value measurement; general M&A governance is insufficient.

1. 49 words maximum. Describe an earn-out measure that changed because the buyer altered channels, investment or product structure.
2. 49 words maximum. Which seller, executive, customer, adviser, auditor or valuation interests require board disclosure?
3. 49 words maximum. How would you distinguish contractual achievement from the accounting fair value of contingent consideration?